Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: A randomized control trial

Journal of Parenteral and Enteral Nutrition

Volumn 38, Issue 6, 2014, Pages 736-743

  Puskarich, Michael A ^a   Kline, Jeffrey A ^b   Krabill, Virginia ^c   Claremont, Heather ^c   Jones, Alan E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

carnitine; L carnitine; randomized control trial; sepsis; shock

Indexed keywords

ADRENALIN; CARNITINE; DOPAMINE; HEPARIN; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE; PLACEBO; SODIUM CHLORIDE; STEROID; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DISEASE; CENTRAL CORD SYNDROME; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONSENSUS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG INFUSION; DRUG SAFETY; END STAGE RENAL DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; INFECTION; INFESTATION; LIVER DYSFUNCTION; LONG TERM SURVIVAL; LUNG EMBOLISM; MALE; MORTALITY; MYOPATHY; NAUSEA AND VOMITING; NEOPLASM; OBSTRUCTIVE JAUNDICE; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETURN OF SPONTANEOUS CIRCULATION; SEIZURE; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHORT TERM SURVIVAL; SKIN ABSCESS; SURVIVAL TIME; THROMBOCYTOPENIA; AFRICAN AMERICAN; BODY MASS; CARDIOMYOPATHIES; CAUCASIAN; DEFICIENCY; DOSE RESPONSE; HYPERAMMONEMIA; MIDDLE AGED; MUSCULAR DISEASES; SHOCK, SEPTIC; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; BODY MASS INDEX; CARDIOMYOPATHIES; CARNITINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERAMMONEMIA; MALE; MIDDLE AGED; MUSCULAR DISEASES; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84904509497     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607113495414     Document Type: Article

References (16)

1. Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 ; 29: 1303-1310 (Pubitemid 32641789)
2. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002 ; 288: 862-871
3. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 ; 344: 699-709 (Pubitemid 32204987)
4. Fink M. Bench-to-bedside review: cytopathic hypoxia. Crit Care. 2002 ; 6: 491-499 (Pubitemid 35414580)
5. Eaton S, Fukumoto K, Stefanutti G, Spitz L, Zammit VA, Pierro A. Myocardial carnitine palmitoyltransferase 1 as a target for oxidative modification in inflammation and sepsis. Biochem Soc Trans. 2003 ; 31: 1133-1136 (Pubitemid 38030924)
6. Vary TC. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate [abstract]. Shock. 1996 ; 6: 89-94 (Pubitemid 126727745)
7. Nani G, Pittiruti M, Giovannini I, Boldrini G, Ronconi P, Castagneto M. Plasma carnitine levels and urinary carnitine excretion during sepsis. JPEN J Parenter Enteral Nutr. 1985 ; 9: 483-490 (Pubitemid 15060513)
8. Gasparetto A, Corbucci GG, de Blasi RA, et al. Influence of acetyl-L-carnitine infusion on haemodynamic parameters and survival of circulatory-shock patients. Int J Clin Pharm Res. 1991 ; 11: 83-92
9. Bone R, Balk R, Cerra F, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine ; 1992 ; 1992. 1644.
10. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996 ; 22: 707-710 (Pubitemid 26254283)
11. Siddiqui FS, Kumar A, Woodward B, Wang Y. Cumulative vasopressor index (CVI) as an assessment of cardiovascular organ dysfunction and indicator of outcome in patients with septic shock. Crit Care Med. 2007 ; 35: A7
12. Jones AE, Focht A, Horton JM, Kline JA. Prospective external validation of the clinical effectiveness of an emergency department-based early goal directed therapy protocol for severe sepsis and septic shock. Chest. 2007 ; 132: 425-432 (Pubitemid 47282372)
13. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 ; 360: 1283-1297
14. Jones A, Stiell I, Nesbitt L, et al. Nontraumatic out-of-hospital hypotension predicts in-hospital mortality. Ann Emerg Med. 2004 ; 43: 106-113 (Pubitemid 38049535)
15. FDA clinical review drotrecogin alfa (activated) [recombinant human activated protein C (rhAPC)] Xigris. 2012. http://www.fda.gov/downloads/drugs/ developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/ therapeuticbiologicapplications/ucm113438.pdf
16. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 ; 286: 1754-1758 (Pubitemid 33010262)